Muscle-specific MicroRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy

Journal of Biological Chemistry

Volumn 288, Issue 9, 2013, Pages 6663-6678

  Kukreti, Himani ^a   Amuthavalli, Kottaiswamy ^a   Harikumar, Arigela ^b,d   Sathiyamoorthy, Sushmitha ^a   Feng, Peng Zhao ^a   Anantharaj, Rengaraj ^a   Tan, Suan Liang Kelvin ^a   Lokireddy, Sudarsanareddy ^b   Bonala, Sabeera ^b   Sriram, Sandhya ^b   McFarlane, Craig ^c   Kambadur, Ravi ^b,c   Sharma, Mridula ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONES; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 70; HIGH DOSE; MOUSE MODELS; MYOSTATIN; MYOTUBES; NUCLEAR TRANSLOCATIONS; SKELETAL MUSCLE; UP-REGULATION;

MUSCLE; PHOSPHORYLATION;

PROTEINS;

ATROGIN 1; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 70; MICRORNA 1; MUSCLE RING FINGER 1 PROTEIN; MYOSTATIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MOLECULAR MECHANICS; MOUSE; MUSCLE ATROPHY; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHO CELLS; CRICETINAE; CRICETULUS; DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTORS; HSP70 HEAT-SHOCK PROTEINS; MICE; MICE, KNOCKOUT; MICRORNAS; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MUSCULAR ATROPHY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84874781146     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.390369     Document Type: Article

References (46)

1. Rhen, T., and Cidlowski, J. A. (2005) Anti-inflammatory action of glucocorticoids. New mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723
2. Hasselgren, P. O. (1999) Glucocorticoids and muscle catabolism. Curr. Opin. Clin. Nutr. Metab. Care 2, 201-205
3. Wing, S. S., and Goldberg, A. L. (1993) Glucocorticoids activate the ATPubiquitin- dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264, E668-676
4. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., Pan, Z. Q., Valenzuela, D. M., DeChiara, T. M., Stitt, T. N., Yancopoulos, G. D., and Glass, D. J. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708
5. Latres, E., Amini, A. R., Amini, A. A., Griffiths, J., Martin, F. J., Wei, Y., Lin, H. C., Yancopoulos, G. D., and Glass, D. J. (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol. Chem. 280, 2737-2744
6. Cohen, S., Brault, J. J., Gygi, S. P., Glass, D. J., Valenzuela, D. M., Gartner, C., Latres, E., and Goldberg, A. L. (2009) During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J. Cell Biol. 185, 1083-1095
7. Schakman, O., Gilson, H., Kalista, S., and Thissen, J. P. (2009) Mechanisms of muscle atrophy induced by glucocorticoids. Horm. Res. 72, 36-41
8. Zhao, W., Qin, W., Pan, J., Wu, Y., Bauman, W. A., and Cardozo, C. (2009) Dependence of dexamethasone-induced Akt/FOXO1 signaling, up-regulation of MAFbx, and protein catabolism upon the glucocorticoid receptor. Biochem. Biophys. Res. Commun. 378, 668-672
9. Clarke, B. A., Drujan, D., Willis, M. S., Murphy, L. O., Corpina, R. A., Burova, E., Rakhilin, S. V., Stitt, T. N., Patterson, C., Latres, E., and Glass, D. J. (2007) The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 6, 376-385
10. Lokireddy, S., McFarlane, C., Ge, X., Zhang, H., Sze, S. K., Sharma, M., and Kambadur, R. (2011) Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol. Endocrinol. 25, 1936-1949
11. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., and Goldberg, A. L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412
12. Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., and Glass, D. J. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395-403
13. Li, B. G., Hasselgren, P. O., Fang, C. H., and Warden, G. D. (2004) Insulinlike growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways. 2002 ABA paper. J. Burn Care Rehabil. 25, 112-118
14. McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M., and Kambadur, R. (2006) Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κBindependent, FoxO1-dependent mechanism. J. Cell Physiol. 209, 501-514
15. Ma, K., Mallidis, C., Bhasin, S., Mahabadi, V., Artaza, J., Gonzalez-Cadavid, N., Arias, J., and Salehian, B. (2003) Glucocorticoid-induced skeletal muscle atrophy is associated with up-regulation of myostatin gene expression. Am. J. Physiol. Endocrinol. Metab. 285, E363-371
16. Gilson, H., Schakman, O., Combaret, L., Lause, P., Grobet, L., Attaix, D., Ketelslegers, J. M., and Thissen, J. P. (2007) Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148, 452-460
17. Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., Rappsilber, J., Mann, M., and Dreyfuss, G. (2002) miRNPs. A novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16, 720-728
18. Stefani, G., and Slack, F. J. (2008) Small non-coding RNAs in animal de- velopment. Nat. Rev. Mol. Cell Biol. 9, 219-230
19. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., and Wang, D. Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233
20. Nakasa, T., Ishikawa, M., Shi, M., Shibuya, H., Adachi, N., and Ochi, M. (2010) Acceleration of muscle regeneration by local injection of musclespecific microRNAs in rat skeletal muscle injury model. J. Cell Mol. Med. 14, 2495-2505
21. McCarthy, J. J., and Esser, K. A. (2007) MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J. Appl. Physiol. 102, 306-313
22. Elia, L., Contu, R., Quintavalle, M., Varrone, F., Chimenti, C., Russo, M. A., Cimino, V., De Marinis, L., Frustaci, A., Catalucci, D., and Condorelli, G. (2009) Reciprocal regulation of microRNA-1 and insulin-like growth factor- 1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120, 2377-2385
23. Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., and Lee, S. J. (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488
24. Sriram, S., Subramanian, S., Sathiakumar, D., Venkatesh, R., Salerno, M. S., McFarlane, C. D., Kambadur, R., and Sharma, M. (2011) Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB. Aging Cell 10, 931-948
25. McFarlane, C., Hui, G. Z., Amanda, W. Z., Lau, H. Y., Lokireddy, S., Xiaojia, G., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M., and Kambadur, R. (2011) Human myostatin negatively regulates human myoblast growth and differentiation. Am. J. Physiol. Cell Physiol. 301, C195-203
26. Massey, A. J., Williamson, D. S., Browne, H., Murray, J. B., Dokurno, P., Shaw, T., Macias, A. T., Daniels, Z., Geoffroy, S., Dopson, M., Lavan, P., Matassova, N., Francis, G. L., Graham, C. J., Parsons, R., Wang, Y., Padfield, A., Comer, M., Drysdale, M. J., and Wood, M. (2010) A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother. Pharmacol. 66, 535-545
27. Siriett, V., Salerno, M. S., Berry, C., Nicholas, G., Bower, R., Kambadur, R., and Sharma, M. (2007) Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol. Ther. 15, 1463-1470
28. Yaffe, D., and Saxel, O. (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727
29. Kambadur, R., Sharma, M., Smith, T. P., and Bass, J. J. (1997) Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 7, 910-916
30. Ye, S., Eriksson, P., Hamsten, A., Kurkinen, M., Humphries, S. E., and Henney, A. M. (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 271, 13055-13060
31. Bonala, S., Lokireddy, S., Arigela, H., Teng, S., Wahli, W., Sharma, M., McFarlane, C., and Kambadur, R. (2012) Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity. J. Biol. Chem. 287, 12935-12951
32. Zeng, X. C., Bhasin, S., Wu, X., Lee, J. G., Maffi, S., Nichols, C. J., Lee, K. J., Taylor, J. P., Greene, L. E., and Eisenberg, E. (2004) Hsp70 dynamics in vivo. Effect of heat shock and protein aggregation. J. Cell Sci. 117, 4991-5000
33. Luo, G., Sun, X., Hungness, E., and Hasselgren, P. O. (2001) Heat shock protects L6 myotubes from catabolic effects of dexamethasone and prevents down-regulation of NF-κB. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1193-1200
34. Senf, S. M., Dodd, S. L., McClung, J. M., and Judge, A. R. (2008) Hsp70 overexpression inhibits NF-κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J. 22, 3836-3845
35. Shan, Z. X., Lin, Q. X., Deng, C. Y., Zhu, J. N., Mai, L. P., Liu, J. L., Fu, Y. H., Liu, X. Y., Li, Y. X., Zhang, Y. Y., Lin, S. G., and Yu, X. Y. (2010) miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 584, 3592-3600
36. Kim, H. K., Lee, Y. S., Sivaprasad, U., Malhotra, A., and Dutta, A. (2006) Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell Biol. 174, 677-687
37. Welch, S., Plank, D., Witt, S., Glascock, B., Schaefer, E., Chimenti, S., Andreoli, A. M., Limana, F., Leri, A., Kajstura, J., Anversa, P., and Sussman, M. A. (2002) Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ. Res. 90, 641-648
38. McArdle, A., Dillmann, W. H., Mestril, R., Faulkner, J. A., and Jackson, M. J. (2004) Overexpression of HSP70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. FASEB J. 18, 355-357
39. Dodd, S., Hain, B., and Judge, A. (2009) Hsp70 prevents disuse muscle atrophy in senescent rats. Biogerontology 10, 605-611
40. Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., and Goldberg, A. L. (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18, 39-51
41. Senf, S. M., Dodd, S. L., and Judge, A. R. (2010)FOXOsignaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Am. J. Physiol. Cell Physiol. 298, C38-45
42. Kayama, M., Nakazawa, T., Thanos, A., Morizane, Y., Murakami, Y., Theodoropoulou, S., Abe, T., Vavvas, D., and Miller, J. W. (2011) Heat shock protein 70 (HSP70) is critical for the photoreceptor stress response after retinal detachment via modulating anti-apoptotic Akt kinase. Am. J. Pathol. 178, 1080-1091
43. Dittmar, K. D., and Pratt, W. B. (1997) Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90·p60·hsp70-dependent step is sufficient for creating the steroid binding conformation. J. Biol. Chem. 272, 13047-13054
44. Ma, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N., and Bhasin, S. (2001) Characterization of 5'-regulatory region of human myostatin gene. Regulation by dexamethasone in vitro. Am. J. Physiol. Endocrinol. Metab. 281, E1128-1136
45. Allen, D. L., and Loh, A. S. (2011) Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoidmediated myostatin expression in skeletal muscle. Am. J. Physiol. Cell Physiol. 300, C124-137
46. Rachagani, S., Cheng, Y., and Reecy, J. M. (2010) Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle. BMC Res. Notes 3, 297-301